In October 2015, two major players in the healthcare industry announced a possible merger between the two. Pfizer is known for its products as Lyrica and Viagra; similarly, Allergan is known for its Botox and Restasis (La Monica, 2015). If those two major players were two merge, a health care oligopoly could be the result. By allowing the merging of these two companies, they would become a major rival to the industry’s leader which is JNJ. Additionally, by sharing a small number of producers in an industry a fixing of prices could occur, which would affect American consumers and since the health care industry affects every American household, these implications could be dangerous. In a similar manner, having fewer choices is not a desirable
